[Skip to Navigation]
Citations 0
Poster Presentations: American Head and Neck Society
August 2006

P152 Treatment of Dysplastic Oral Mucosal Lesions With a New Cell Cycle–Inhibiting Agent

Arch Otolaryngol Head Neck Surg. 2006;132(8):894-895. doi:10.1001/archotol.132.8.894-c

Institute of Medical Sciences, Varanasi, India;

Johns Hopkins University, Baltimore, Md;

Regional Cancer Center, Trivandrum, India

Objective: Oral cancer is associated with tobacco habit and is preceded in most cases by premalignant lesions. An approach to cancer control is to identify potentially malignant or premalignant lesions where treatment of these lesions may prevent transformation to cancer. The present study was carried out to evaluate the clinical and molecular response of intralesional tetra-O-methyl nordihydroguaiaretic acid in oral premalignant lesions.

×